BioProcess International Announces Finalists for the 2014 BioProcess International Awards
New York, NY (PRWEB) October 02, 2014 -- BioProcess International (BPI), a business-to-business publication, today announced the finalists for the 2014 BioProcess International Awards. The awards celebrate the outstanding achievements, collaborations, business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base. Award winners and finalists from around the world, will be recognized at a special dinner and ceremony during the 2014 BioProcess International Conference on Wednesday, 22 October 2014, at the Hynes Convention Center in Boston, MA.
“These prestigious award finalists represent the people, organizations and technology applications that define excellence, best practices, and promising collaborations that allow our industry remain innovative and on the cutting-edge," said Brian Caine, Publisher of BioProcess International. "Congratulations to each finalist on this incredible achievement.”
Categories and finalists appear below. A complete list, including the BPI Honors, a distinct recognition of two Industry Champions, is available at http://www.bioprocessintl.com/finalist.
BioProcess International 2014 Award Finalists
Excellence in Leadership — honors the strong leaders and mentors who have successfully driven biopharmaceutical commercial success through motivating their teams for growth and innovation.
• Lynn Bottone, Site Leader, Sanford Site, Pfizer
• Olivier Loeillot, General Manager, Enterprise Solutions, GE Healthcare Life Sciences
• Dr. Robert Preti, Founder, President, and Chief Scientific Officer, Progenitor Cell Therapy (PCT)
Emerging Company — honors the biopharmaceutical companies to watch and those that have successfully raised awareness within the scientific community.
• BioCision
• Horizon
• ToleRaM Nanotech, LLC.
Corporate Citizenship — honors the companies that have made significant contributions through activities within a broader urban or regional community.
• Bayer HealthCare
• Biogen Idec
• Sigma-Aldrich
Excellence in Facility Design or Retrofit — honors a biotech facility that exemplifies innovation through the use of key technologies and/or designs.
• Gallus BioPharmaceuticals/GE Healthcare Life Sciences
• Vetter
• FUJIFILM Diosynth Biotechnologies
Best Collaboration — honors promising collaborations that have proven to result in significant benefits toward accelerating drug development or mitigating risks.
• Invetech Inc./Janssen Research & Development, LLC
• Promosome/GE Healthcare Life Sciences
• TAP Biosystems/Merck & Co., Inc.
Upstream: Best Technology Applications — honors a user or supplier that through the adoption and application of a technology is paving the way toward a new approach to biopharmaceutical process design.
• XDR-50 MO Fermentor System — GE Healthcare Life Sciences
• STX® Scalable Transfection System — MaxCyte
• ambr250 — TAP Biosystems/Merck & Co., Inc.
Downstream: Best Technology Applications — honors a user or supplier whose new technologies show, though well-documented applications for bioprocessing, that they are indeed game-changers.
• BioT Temperature Stability Systems — BioCision
• Allegro Single-Use Filling Needles — Pall Life Sciences/Disposable-Lab SAS
• Natrix HD Membranes — Natrix Separations, Inc. /Gallus BioPharmaceuticals
Analytical: Best Technology Applications — honors a user or supplier that has demonstrated increased functionality in novel combinations with other analytical technologies, whether old or new; or the technologies may reveal significant benefit in new bioprocessing applications — including emerging product sectors.
• MicroScale Thermophoresis (MST) — NanoTemper Technologies GmbH
• ImageStreamX®(ISX) — Enzo Life Sciences/Amnis (part of EMD Millipore)
• SGS M-Scan Services — SGS Life Sciences
The 2014 BioProcess International Awards Ceremony
The 2014 BioProcess International Awards program culminates with a special dinner and ceremony taking place on October 22, 2014, at the BioProcess International Conference and Exhibition, in Boston, MA. To purchase tickets to the awards dinner and ceremony ($125.00) and receive a complimentary exhibit-hall-only pass, please click on the following link, enter code BP14BPANE, choose your registration preference and select the BioProcess Awards Ceremony & Dinner as your second option. https://www.ibclifesciences.com/BPI/register.xml?step=start
About Our Sponsors
Program Sponsors:
GE Healthcare Life Sciences provides tools and technologies, solutions, and services that enable the biopharmaceutical industry to develop and manufacture biotherapeutic medicines and vaccines cost-effectively. Our products and platform solutions are designed to meet the key challenges posed at every stage in the biomanufacturing process, delivering the desired product at the required purity and safety — all with fast development and integrated solutions in mind. Across the bioprocessing spectrum, our focus is on supporting the industry from idea to result. http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeSciences-US/products-and-solutions/bioprocessing/
Pall Life Sciences provides process, pilot and laboratory filtration, separation, purification, and fluid handling devices, systems, and services with single-use systems available for all unit operations from cell culture through final formulation and filling. Based on Pall’s long history of providing quality equipment for the biopharmaceutical, vaccine, and cell therapy industries, all products — whether standard or customized to match users exact process needs — are backed up with extensive documentation and experience in extractables, leachables, and particulate validation. Fully automated single-use systems allow process control and data acquisition to meet or exceed the standards expected from traditional fixed equipment. New product highlights include microcarriers, pyrogen-free vials, and a range of pharmaceutical packaging. http://www.pall.com/main/biopharmaceuticals/biopharmaceuticals-bdb09025.page?
Sartorius Stedim Biotech is one of the world's leading providers of laboratory and process technologies and equipment. Our innovative products and high-quality services help customers implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. Sartorius Stedim Biotech introduced the first single-use bag for biopharmaceutical applications. Demand for these bioprocessing bags has rapidly increased for use in critical applications. We have developed a new polyethylene film and new bioprocessing bags to pave the way toward the single-use manufacturing facility of the future. Flexsafe meets the most stringent customer needs for safe bioprocessing. http://www.sartorius.com/
Associate Sponsor:
Rentschler is an independent, family-owned biopharmaceutical CMO with a long-term track record, high level of flexibility, and tailored project performance. Our full-service concept covers development, production of recombinant proteins in mammalian cell lines, fill–finish and international regulatory expertise. Our state-of-the-art facilities with bioreactors up to 3,500 L total volume and our quality control ensure highest quality.
http://www.rentschler.de
To view award program details, please visit: http://www.bioprocessintl.com/awards
About BioProcess International
BioProcess International (BPI) is a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics. Learn more at http://www.bioprocessintl.com.
Leah Rosin, BioProcess International, http://www.bioprocessintl.com, +1 508-614-1677, [email protected]
Share this article